The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, S.
Right arrow Articles by Braley-Mullen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, S.
Right arrow Articles by Braley-Mullen, H.
The Journal of Immunology, 2006, 176: 1259-1265.
Copyright © 2006 by The American Association of Immunologists

Thyrocytes Responding to IFN-{gamma} Are Essential for Development of Lymphocytic Spontaneous Autoimmune Thyroiditis and Inhibition of Thyrocyte Hyperplasia1

Shiguang Yu*, Gordon C. Sharp*,{dagger} and Helen Braley-Mullen2,*,{ddagger},§

* Department of Internal Medicine, {dagger} Department of Pathology, and {ddagger} Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO 65212; and § Department of Veterans Affairs, Research Service, Columbia, MO 65212

IFN-{gamma} promotes the development of lymphocytic spontaneous autoimmune thyroiditis (L-SAT) in NOD.H-2h4 mice and inhibits the development of thyrocyte hyperplasia and proliferation (TEC H/P). The precise mechanisms by which IFN-{gamma} promotes L-SAT and inhibits TEC H/P are unknown. To determine whether responsiveness of lymphocytes or thyrocytes to IFN-{gamma} is important for the development of these lesions, IFN-{gamma}R–/– mice, which develop TEC H/P similar to IFN-{gamma}–/– mice, were used as recipients for adoptive cell transfer. Wild-type (WT) splenocytes or bone marrow induced L-SAT and inhibited TEC H/P in IFN-{gamma}–/–, but not IFN-{gamma}R–/– recipients. IFN-{gamma}R–/– recipients of WT cells developed severe TEC H/P, but did not develop L-SAT, suggesting that thyrocytes responding to IFN-{gamma} are important for inhibition of TEC H/P. Unexpectedly, IFN-{gamma}R–/– splenocytes or bone marrow did not induce L-SAT in IFN-{gamma}–/– or WT mice even though IFN-{gamma}R–/– lymphocyte donors produced as much IFN-{gamma} as lymphocytes from WT donors, and thyrocytes could respond to IFN-{gamma}. Real-time PCR indicated that recipients of IFN-{gamma}R–/– bone marrow expressed less mRNA for IFN-{gamma}-inducible chemokines compared with recipients of WT bone marrow. This might limit the migration of IFN-{gamma}R–/– lymphocytes to thyroids. Few IFN-{gamma}R–/– lymphocytes infiltrated thyroids even in the presence of WT lymphocytes, suggesting that lymphocytes unable to respond to IFN-{gamma} are not induced to migrate to thyroids. These results suggest that thyrocytes must be able to respond to IFN-{gamma} for the development of L-SAT and inhibition of TEC H/P, and lymphocytes must be able to respond to IFN-{gamma} to induce L-SAT.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Yu, G. C. Sharp, and H. Braley-Mullen
TGF-{beta} Promotes Thyroid Epithelial Cell Hyperplasia and Fibrosis in IFN-{gamma}-Deficient NOD.H-2h4 Mice
J. Immunol., August 1, 2008; 181(3): 2238 - 2245.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Poncin, B. Lengele, I. M. Colin, and A.-C. Gerard
Differential Interactions between Th1/Th2, Th1/Th3, and Th2/Th3 Cytokines in the Regulation of Thyroperoxidase and Dual Oxidase Expression, and of Thyroglobulin Secretion in Thyrocytes in Vitro
Endocrinology, April 1, 2008; 149(4): 1534 - 1542.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.